Nuveen Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $975K | Hold |
291,091
| – | – | ﹤0.01% | 2723 |
|
|
2024
Q3 | $975K | Hold |
291,091
| – | – | ﹤0.01% | 2773 |
|
|
2024
Q2 | $964K | Hold |
291,091
| – | – | ﹤0.01% | 2746 |
|
|
2024
Q1 | $1.18M | Hold |
291,091
| – | – | ﹤0.01% | 2632 |
|
|
2023
Q4 | $888K | Buy |
291,091
+1,598
| +0.6% | +$4.87K | ﹤0.01% | 2788 |
|
|
2023
Q3 | $868K | Sell |
289,493
-2,598
| -0.9% | -$7.79K | ﹤0.01% | 2631 |
|
|
2023
Q2 | $1.09M | Sell |
292,091
-93,331
| -24% | -$349K | ﹤0.01% | 2610 |
|
|
2023
Q1 | $1.29M | Buy |
385,422
+72,018
| +23% | +$241K | ﹤0.01% | 2511 |
|
|
2022
Q4 | $1.51M | Sell |
313,404
-34,519
| -10% | -$166K | ﹤0.01% | 2502 |
|
|
2022
Q3 | $1.98M | Buy |
347,923
+77,760
| +29% | +$443K | ﹤0.01% | 2409 |
|
|
2022
Q2 | $1.92M | Buy |
270,163
+17,150
| +7% | +$122K | ﹤0.01% | 2453 |
|
|
2022
Q1 | $1.75M | Sell |
253,013
-15,085
| -6% | -$105K | ﹤0.01% | 2563 |
|
|
2021
Q4 | $2.4M | Sell |
268,098
-592
| -0.2% | -$5.29K | ﹤0.01% | 2481 |
|
|
2021
Q3 | $9.42M | Sell |
268,690
-33,550
| -11% | -$1.18M | ﹤0.01% | 1822 |
|
|
2021
Q2 | $6.49M | Buy |
302,240
+247,027
| +447% | +$5.31M | ﹤0.01% | 2107 |
|
|
2021
Q1 | $3.41M | Buy |
55,213
+2,122
| +4% | +$131K | ﹤0.01% | 2356 |
|
|
2020
Q4 | $2.22M | Buy |
+53,091
| New | +$2.22M | ﹤0.01% | 2458 |
|